location: Current position: Home >> Scientific Research >> Paper Publications

Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity

Hits:

Affiliation of Author(s):药学院

Journal:Journal of Medicianal Chemistry

Document Code:1843556113689186305

Volume:67

Issue:18

Page Number:16480-16504

Number of Words:9

Translation or Not:no

Date of Publication:2024-09-12

Pre One:Simultaneous inhibition of FLT3 and HDAC by novel 6-ethylpyrazine-2-Carboxamide derivatives provides therapeutic advantages in acute myelocytic leukemia

Next One:Design and synthesis of novel benzoic acid derivatives as striatal-enriched protein tyrosine phosphatase (STEP) inhibitors with neuroprotective properties